FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892342662> ?p ?o ?g. }

• W2892342662 abstract "Neoadjuvant chemotherapy (NAC) significantly extends survival in advanced esophageal squamous cell carcinoma (ESCC), but the short-term outcomes for cT4 ESCC remain controversial. Many NAC regimens have been previously reported, although no study has reported a regimen of irinotecan and nedaplatin for cT4 potential resectable ESCC. We evaluated the short-term outcomes of NAC with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable ESCC. A total of 51 patients with cT4 potentially resectable ESCC were eligible for this study. Twenty of these patients underwent NAC, and the other 31 patients underwent surgery alone. The toxicities and response of NAC were evaluated. The clinicopathologic characteristics, responses, toxicities, surgical outcomes, postoperative complications, and survival time between the two groups were analyzed. No significant differences were found in clinicopathologic characteristics between the groups (P > 0.05). The response rate of NAC was 75% (15/20). The differences in the long-axis diameter of the tumor and cT stage between pre- and post-NAC were significant (P < 0.05). Twenty-four toxic events occurred in 11 patients of the NAC group, and 20/24 of these were mild. The R0 resection rates in the NAC group and the surgery alone group were 85% and 64.5%, with no statistically significant difference (P > 0.05). Differences in the pathological T stage and pathological tumor-node-metastasis (TNM) stage were significant (P < 0.05). The overall survival (OS) time and mortality in the NAC group versus the surgery alone group were 31.57 ± 3.06 months versus 15.24 ± 1.46 months and 25% versus 61.3%, respectively. The differences in OS and mortality were significant (P < 0.05). The NAC group and R0 resection were significant and independent predictors of positive prognosis. NAC with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable ESCC as a new NAC is safe and effective." @default.
• W2892342662 created "2018-09-27" @default.
• W2892342662 creator A5000800244 @default.
• W2892342662 creator A5030988755 @default.
• W2892342662 creator A5056470318 @default.
• W2892342662 creator A5057735128 @default.
• W2892342662 creator A5065213965 @default.
• W2892342662 creator A5072470698 @default.
• W2892342662 creator A5079832482 @default.
• W2892342662 creator A5089684120 @default.
• W2892342662 date "2018-08-27" @default.
• W2892342662 modified "2023-09-23" @default.
• W2892342662 title "Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes" @default.
• W2892342662 cites W1492446407 @default.
• W2892342662 cites W1907999036 @default.
• W2892342662 cites W1920900131 @default.
• W2892342662 cites W1964008808 @default.
• W2892342662 cites W1964979440 @default.
• W2892342662 cites W1970220955 @default.
• W2892342662 cites W1977242569 @default.
• W2892342662 cites W1977450976 @default.
• W2892342662 cites W1978350956 @default.
• W2892342662 cites W1980296058 @default.
• W2892342662 cites W1982613875 @default.
• W2892342662 cites W1988248045 @default.
• W2892342662 cites W1995318267 @default.
• W2892342662 cites W2001175328 @default.
• W2892342662 cites W2001479598 @default.
• W2892342662 cites W2013835366 @default.
• W2892342662 cites W2017063398 @default.
• W2892342662 cites W2023272328 @default.
• W2892342662 cites W2024504178 @default.
• W2892342662 cites W2026288882 @default.
• W2892342662 cites W2030931565 @default.
• W2892342662 cites W2034360097 @default.
• W2892342662 cites W2034451221 @default.
• W2892342662 cites W2045830855 @default.
• W2892342662 cites W2049062589 @default.
• W2892342662 cites W2050136440 @default.
• W2892342662 cites W2050746528 @default.
• W2892342662 cites W2051766264 @default.
• W2892342662 cites W2054536599 @default.
• W2892342662 cites W2055992536 @default.
• W2892342662 cites W2059795534 @default.
• W2892342662 cites W2068219429 @default.
• W2892342662 cites W2071014402 @default.
• W2892342662 cites W2073156652 @default.
• W2892342662 cites W2075362684 @default.
• W2892342662 cites W2079792556 @default.
• W2892342662 cites W2094712821 @default.
• W2892342662 cites W2099709180 @default.
• W2892342662 cites W2115054338 @default.
• W2892342662 cites W2117089661 @default.
• W2892342662 cites W2132832509 @default.
• W2892342662 cites W2143826746 @default.
• W2892342662 cites W2150453648 @default.
• W2892342662 cites W2152372628 @default.
• W2892342662 cites W2154444715 @default.
• W2892342662 cites W2155217640 @default.
• W2892342662 cites W2165225273 @default.
• W2892342662 cites W2165466723 @default.
• W2892342662 cites W2169110063 @default.
• W2892342662 cites W2207624802 @default.
• W2892342662 cites W2314291476 @default.
• W2892342662 cites W2338880854 @default.
• W2892342662 cites W2520298476 @default.
• W2892342662 cites W2604141495 @default.
• W2892342662 cites W2617251978 @default.
• W2892342662 cites W2728674371 @default.
• W2892342662 cites W2729284987 @default.
• W2892342662 cites W2801855289 @default.
• W2892342662 cites W38547746 @default.
• W2892342662 doi "https://doi.org/10.1093/dote/doy080" @default.
• W2892342662 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30247659" @default.
• W2892342662 hasPublicationYear "2018" @default.
• W2892342662 type Work @default.
• W2892342662 sameAs 2892342662 @default.
• W2892342662 citedByCount "2" @default.
• W2892342662 countsByYear W28923426622021 @default.
• W2892342662 countsByYear W28923426622023 @default.
• W2892342662 crossrefType "journal-article" @default.
• W2892342662 hasAuthorship W2892342662A5000800244 @default.
• W2892342662 hasAuthorship W2892342662A5030988755 @default.
• W2892342662 hasAuthorship W2892342662A5056470318 @default.
• W2892342662 hasAuthorship W2892342662A5057735128 @default.
• W2892342662 hasAuthorship W2892342662A5065213965 @default.
• W2892342662 hasAuthorship W2892342662A5072470698 @default.
• W2892342662 hasAuthorship W2892342662A5079832482 @default.
• W2892342662 hasAuthorship W2892342662A5089684120 @default.
• W2892342662 hasConcept C121608353 @default.
• W2892342662 hasConcept C126322002 @default.
• W2892342662 hasConcept C141071460 @default.
• W2892342662 hasConcept C143998085 @default.
• W2892342662 hasConcept C146357865 @default.
• W2892342662 hasConcept C151730666 @default.
• W2892342662 hasConcept C2776283816 @default.
• W2892342662 hasConcept C2776694085 @default.
• W2892342662 hasConcept C2777297899 @default.
• W2892342662 hasConcept C2777546739 @default.
• W2892342662 hasConcept C2778203143 @default.

• next